Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-09

Clinical Trial Update: Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn

View source ↗

Summary

This completed study from Paris hospitals examined how exposure to anti-integrase therapies during pregnancy affects the newborn's lymphocyte repertoire.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Integrase inhibitors (class) (Integrase inhibitor)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Anti-integrases | Status: COMPLETED